Former Vice Premier Tsai Ing-wen (蔡英文) and AIDS research pioneer David Ho (何大一) will lead a new biotech company that will be jointly owned by the government and private investors to speed up the research and development of AIDS drugs, the nation's top economic planner said yesterday.
Ho Mei-yueh (何美玥), chairwoman of the Council for Economic Planning and Development, said the state-owned National Development Fund (NDF) would help finance the establishment of TaiMed Biologics Co (宇昌生技), which is planning to raise US$50 million in capital. Mo said the NDF plans to hold a 40 percent share in the company.
The government has authorized Tsai to assume the chairmanship and David Ho, a Taiwan-born AIDS expert and director of the New York-based Aaron Diamond AIDS Research Center, would serve as a co-founder of TaiMed Biologics, which would be a subsidiary of TaiMed Inc (台懋公司), a Taiwan-based biotech firm, Ho said.
Noting that TaiMed Biologics has gained patent authorization from US-based Genentech Inc for its lead clinical product, TNX-355, a potential treatment for HIV and AIDS patients, Ho said it marks a breakthrough in Taiwan's biotech industry.
She said the US company reported positive results in a Phase 2 clinical trial of TNX-355 and that a Phase 2b trial is expected to be conducted in the fourth quarter of this year in the US, Europe and South America.
TaiMed Biologics will be located in the Hsinchu Biomedical Park (新竹生醫園區) and will be the first enterprise to be set up in the park.
Other members of the TaiMed Biologics board of directors include Academia Sinica President Wong Chi-huey (翁啟惠), Lee Yuan-tseh (李遠哲), a Nobel laureate and former president of the Academic Sinica and Chen Lan-bo (陳良博), founder of Synta Pharmaceuticals Corp, a biopharmaceutical company.
Nvidia Corp chief executive officer Jensen Huang (黃仁勳) on Monday introduced the company’s latest supercomputer platform, featuring six new chips made by Taiwan Semiconductor Manufacturing Co (TSMC, 台積電), saying that it is now “in full production.” “If Vera Rubin is going to be in time for this year, it must be in production by now, and so, today I can tell you that Vera Rubin is in full production,” Huang said during his keynote speech at CES in Las Vegas. The rollout of six concurrent chips for Vera Rubin — the company’s next-generation artificial intelligence (AI) computing platform — marks a strategic
Enhanced tax credits that have helped reduce the cost of health insurance for the vast majority of US Affordable Care Act enrollees expired on Jan.1, cementing higher health costs for millions of Americans at the start of the new year. Democrats forced a 43-day US government shutdown over the issue. Moderate Republicans called for a solution to save their political aspirations this year. US President Donald Trump floated a way out, only to back off after conservative backlash. In the end, no one’s efforts were enough to save the subsidies before their expiration date. A US House of Representatives vote
REVENUE PERFORMANCE: Cloud and network products, and electronic components saw strong increases, while smart consumer electronics and computing products fell Hon Hai Precision Industry Co (鴻海精密) yesterday posted 26.51 percent quarterly growth in revenue for last quarter to NT$2.6 trillion (US$82.44 billion), the strongest on record for the period and above expectations, but the company forecast a slight revenue dip this quarter due to seasonal factors. On an annual basis, revenue last quarter grew 22.07 percent, the company said. Analysts on average estimated about NT$2.4 trillion increase. Hon Hai, which assembles servers for Nvidia Corp and iPhones for Apple Inc, is expanding its capacity in the US, adding artificial intelligence (AI) server production in Wisconsin and Texas, where it operates established campuses. This
US President Donald Trump on Friday blocked US photonics firm HieFo Corp’s US$3 million acquisition of assets in New Jersey-based aerospace and defense specialist Emcore Corp, citing national security and China-related concerns. In an order released by the White House, Trump said HieFo was “controlled by a citizen of the People’s Republic of China” and that its 2024 acquisition of Emcore’s businesses led the US president to believe that it might “take action that threatens to impair the national security of the United States.” The order did not name the person or detail Trump’s concerns. “The Transaction is hereby prohibited,”
RSS